PO9-212 EFFECT OF ROSIGLITAZONE ON LEUKOCYTE EXPRESSION OF PROINFLAMMATORY AND PROTHROMBOTIC MOLECULES IN PATIENTS WITH TYPE 2 DIABETES

Authors :: R. Dolezalova
Marinov I
Z. Kasalova
Richard Ceska
Tomáš Štulc
H. Krejci
Helena Svitavská Svobodová
Source :: Atherosclerosis Supplements. 8:69
Publication Year :: 2007
Publisher :: Elsevier BV, 2007.

Subjects :: medicine.medical_specialty
business.industry
General Medicine
Type 2 diabetes
medicine.disease
Proinflammatory cytokine
Endocrinology
Internal medicine
Internal Medicine
medicine
In patient
Cardiology and Cardiovascular Medicine
Rosiglitazone
business
medicine.drug

Tools